CAM
Concorde Asset Management’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-6,526
| Closed | -$284K | – | 124 |
|
|
2017
Q4 | $284K | Sell |
6,526
-1,340
| -17% | -$58.3K | 0.36% | 87 |
|
|
2017
Q3 | $340K | Sell |
7,866
-974
| -11% | -$42.1K | 0.29% | 97 |
|
|
2017
Q2 | $380K | Sell |
8,840
-1,038
| -11% | -$44.6K | 0.51% | 71 |
|
|
2017
Q1 | $410K | Sell |
9,878
-2,735
| -22% | -$114K | 0.68% | 52 |
|
|
2016
Q4 | $429K | Sell |
12,613
-2,013
| -14% | -$68.5K | 0.77% | 50 |
|
|
2016
Q3 | $646K | Sell |
14,626
-1,721
| -11% | -$76K | 0.81% | 37 |
|
|
2016
Q2 | $629K | Sell |
16,347
-4,360
| -21% | -$168K | 0.63% | 37 |
|
|
2016
Q1 | $843K | Sell |
20,707
-4,405
| -18% | -$179K | 0.97% | 28 |
|
|
2015
Q4 | $1.29M | Sell |
25,112
-426
| -2% | -$21.8K | 1.43% | 20 |
|
|
2015
Q3 | $1.2M | Buy |
25,538
+13,606
| +114% | +$638K | 2.03% | 13 |
|
|
2015
Q2 | $1.49M | Buy |
+11,932
| New | +$1.49M | 1.89% | 17 |
|